PhRMA’s Compromise Offer On Drug Safety Would “Clarify” FDA’s Powers

The Pharmaceutical Research and Manufacturers of America is proposing reforms to FDA's safety powers that would allow quicker regulatory actions, but not fundamentally alter the agency's authority